Recovery From Acute Immune Failure in Septic Shock by Immune Cell Extracorporeal Therapy

Summary

Evaluation of a novel therapy approach for severe sepsis patients. Subjects randomized into the treatment arm receive treatment with an immune cell perfusion system on top of standard care. This may contribute to the improvement of the impaired organ function of septic shock patients by assisting the impaired immune system (immune competence enhancement = ARTICE)

Timeline

Start

2022-07-24

Primary completion

2026-03-30

Completion

2026-06-30

Drugs

Indications